David Shaw’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

David Shaw’s Portfolio GNOM Stock Details GNOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-3,665	Closed	-$142K	–	4434
2024 Q4	$142K	Sell	3,665 -2,861	-44%	-$120K	﹤0.01%	4135
2024 Q3	$294K	Buy	6,526 +1,464	+29%	+$65.4K	﹤0.01%	3985
2024 Q2	$211K	Buy	+5,062	New	+$212K	﹤0.01%	4054

Other funds holding GNOM

OCM

One Capital Management Westlake Village, California $3.6B AUM 16.02% 1-Year Est. Return

PGA

Portland Global Advisors Portland, Maine $1.05B AUM 18.22% 1-Year Est. Return

FTUS

Flow Traders U.S. New York $2.43B AUM 44.44% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Mirae Asset Global ETFs Holdings Causeway Bay, Hong Kong $83.9B AUM 60.43% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

IWM

IHT Wealth Management Chicago, Illinois $4.7B AUM 25.67% 1-Year Est. Return

OAM

Oppenheimer Asset Management New York $9.63B AUM 30.32% 1-Year Est. Return

David Shaw's GNOM Position: Q1 2025 in Review

David Shaw sold out of Global X Genomics & Biotechnology ETF (GNOM) in Q1 2025, closing a stake of 3,665 shares — an estimated $142K sold.

David Shaw first reported a position in GNOM in Q2 2024 and held it in 3 quarters. The position peaked at $294K in Q3 2024. 60 funds tracked by Wall St. Rank hold GNOM as of Q1 2025.

David Shaw reported no remaining Global X Genomics & Biotechnology ETF position as of Q1 2025 after selling out during the quarter.
David Shaw sold 3,665 Global X Genomics & Biotechnology ETF shares in Q1 2025, an estimated $142K.
David Shaw first reported a position in Global X Genomics & Biotechnology ETF in Q2 2024 and held it in 3 quarters.
David Shaw's Global X Genomics & Biotechnology ETF position peaked at $294K in Q3 2024.
60 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q1 2025.

Based on D.E. Shaw & Co's 13F filing for Q1 2025, filed 15 May 2025.